News

Silence on E. coli outbreak highlights how Trump team's changes undermine food safety
Colton George felt sick. The 9-year-old Indiana boy told his parents his stomach hurt. He kept running to the bathroom and ...
A Day In Our Shoes on MSN6h
The Vaccine Crisis Isn’t Coming, It’s Here: Kids Are Already at Risk from Low Vaccination Rates.
For most children, illnesses like measles or the flu are unpleasant but manageable. A fever, a rash, some time home from ...
Connecticut Public3h
These researchers think the sludge in your home may help save the planet
What if the solutions to some of Earth's biggest problems could be found in some of its smallest creatures? That bet has led ...
Scientists Discover Bacteria That Can 'Breathe' By Generating Electricity
The process is called extracellular respiration, which mimics how batteries discharge electric current -- allowing bacteria to thrive without oxygen.
Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
New trial arm to evaluate safety, dosing and preliminary anti-tumor activity of the combination therapy in advanced solid tumorsNEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc.